On this page
USH2A
usherin
USH2A is located on the long (q) arm of chromosome 1, at band 1q41. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 1 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The USH2A gene is located on chromosome 1 and encodes usherin, a protein integral to the structural scaffolding of basement membranes in sensory tissues. Basement membranes are thin, sheet-like structures that provide support and organisation to cells, and usherin plays a particularly important role in the inner ear and retina. Pathogenic changes in USH2A are the most frequent cause of Usher syndrome type 2, a condition combining congenital hearing loss with progressive retinal degeneration. USH2A variants also account for a substantial proportion of autosomal recessive retinitis pigmentosa cases without associated hearing impairment. Understanding this gene is essential for families affected by inherited sensory disorders and informs clinical pathways for early detection and management.
What the gene does
Usherin functions as a structural component within basement membranes, the extracellular matrices that separate and support epithelial and other tissue layers. Research suggests that usherin participates in a multi-protein complex essential for the development and long-term maintenance of hair cells in the cochlea and photoreceptor cells in the retina. These sensory cells are highly specialised and depend on precise structural organisation to function correctly. Evidence indicates that usherin may also contribute to synaptic function at junctions between nerve cells, where signals are transmitted during sensory processing. The protein's presence in both auditory and visual tissues explains why USH2A variants typically affect both hearing and sight, though the timing and severity of involvement can vary. Loss of functional usherin disrupts the integrity of these sensory structures, leading to progressive degeneration of hair cells and photoreceptors over time.
Video: Genetics 101
Chromosome location
USH2A is located on the long arm of chromosome 1 at position 1q41. The gene spans a large genomic region and encodes a transcript that produces a protein of 5202 amino acids, making usherin one of the larger proteins in the human proteome. The substantial size of both the gene and its protein product contributes to the complexity of genetic analysis and the diversity of pathogenic variants observed.
Protein structure
Usherin is a large extracellular protein with a modular architecture composed of multiple functional domains. The N-terminal region contains a Laminin N-terminal domain (amino acids 271-517), followed by a series of ten Laminin EGF-like domains spanning amino acids 518 to 1052. These laminin-related domains are thought to facilitate interactions with other basement membrane components and cell-surface receptors. The central and C-terminal portions of the protein feature four Fibronectin type-III domains (amino acids 1058-1468), which typically mediate protein-protein interactions and contribute to the structural framework of the extracellular matrix. This domain organisation reflects usherin's role in assembling and maintaining the complex molecular networks required for proper function of sensory epithelia.
Key variants
Over 400 pathogenic variants have been identified in USH2A, making it one of the most commonly affected genes in hereditary hearing and vision loss. The large size of the gene means that variants can occur throughout its coding sequence, including missense changes, nonsense mutations, and splice-site alterations. Pathogenic variants generally lead to reduced or absent functional usherin protein, disrupting basement membrane integrity in the inner ear and retina.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.1387_1405del | p.Tyr463fs | Pathogenic/Likely pathogenic | ★★☆☆ | Usher syndrome type 2A |
c.1409_1419del | p.Phe470fs | Pathogenic/Likely pathogenic | ★★☆☆ | USH2A-related disorder |
c.14782C>T | p.Gln4928Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Usher syndrome type 2A |
c.250del | p.Cys84fs | Pathogenic | ★★☆☆ | USH2A-related disorder |
c.545_548del | p.Lys182fs | Pathogenic | ★★☆☆ | Usher syndrome type 2A |
c.5933_5940del | p.Pro1978fs | Pathogenic | ★★☆☆ | USH2A-related disorder |
c.5950_5960dup | p.Tyr1987Ter | Pathogenic | ★★☆☆ | USH2A-related disorder |
c.9433_9437delinsAGGAGATCATATCCATTCCATAGGA | p.Leu3145fs | Pathogenic/Likely pathogenic | ★★☆☆ | USH2A-related disorder |
c.10695T>A | p.Tyr3565Ter | Pathogenic | ★☆☆☆ | USH2A-related disorder |
c.131del | p.Gly44fs | Pathogenic | ★☆☆☆ | Retinal disorder |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Pathogenic variants in USH2A are associated with two main clinical presentations. Usher syndrome type 2 is the most common manifestation, characterised by moderate to severe congenital hearing loss and progressive retinitis pigmentosa that typically becomes apparent in adolescence or early adulthood. USH2A variants are responsible for the majority of Usher syndrome type 2 cases. Additionally, USH2A pathogenic variants account for approximately 10 to 15 per cent of autosomal recessive retinitis pigmentosa cases without associated hearing loss, a condition in which light-sensing retinal cells gradually deteriorate, leading to progressive vision impairment.
- Retinitis pigmentosa (multiple)
- Usher syndrome type 2 Dedicated page coming soon
UK clinical status
Within the NHS Genomic Medicine Service, USH2A is included on the Monogenic hearing loss panel (green classification, version R67) and the Retinal disorders panel (green classification, version R32). The green classification indicates strong evidence supporting the gene's role in these conditions, and variants in USH2A are routinely evaluated in clinical diagnostic pathways for patients presenting with hereditary hearing loss or retinal degeneration.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the difference between Usher syndrome type 2 and retinitis pigmentosa caused by USH2A variants?
Usher syndrome type 2 involves both congenital hearing loss and progressive vision loss due to retinitis pigmentosa, whereas some individuals with USH2A variants experience retinitis pigmentosa alone without significant hearing impairment. The specific variants and possibly additional genetic or environmental factors may influence which presentation occurs.
How is USH2A inherited?
USH2A-related conditions follow an autosomal recessive pattern of inheritance. This means an individual must inherit pathogenic variants in both copies of the gene (one from each parent) to develop symptoms. Carriers with one pathogenic variant typically do not experience hearing or vision loss.
Can genetic testing for USH2A help with early diagnosis?
Genetic testing can identify pathogenic USH2A variants in individuals with hearing loss or a family history of Usher syndrome or retinitis pigmentosa, enabling earlier monitoring for retinal degeneration and access to supportive interventions. Early diagnosis allows for timely referral to specialist services and appropriate planning for managing progressive sensory changes.
References
- Blanco-Kelly F, Jaijo T, Aller E. Clinical aspects of Usher syndrome and the USH2A gene in a cohort of 433 patients. JAMA ophthalmology. 2015. PMID: 25375654
- Chen X, Sheng X, Liu X. Targeted next-generation sequencing reveals novel USH2A mutations associated with diverse disease phenotypes: implications for clinical and molecular diagnosis. PloS one. 2014. PMID: 25133613
- McGee TL, Seyedahmadi BJ, Sweeney MO. Novel mutations in the long isoform of the USH2A gene in patients with Usher syndrome type II or non-syndromic retinitis pigmentosa. Journal of medical genetics. 2010. PMID: 20507924
- Sandberg MA, Rosner B, Weigel-DiFranco C. Disease course in patients with autosomal recessive retinitis pigmentosa due to the USH2A gene. Investigative ophthalmology & visual science. 2008. PMID: 18641288
- Liu X, Bulgakov OV, Darrow KN. Usherin is required for maintenance of retinal photoreceptors and normal development of cochlear hair cells. Proceedings of the National Academy of Sciences of the United States of America. 2007. PMID: 17360538
- van Wijk E, Pennings RJ, te Brinke H. Identification of 51 novel exons of the Usher syndrome type 2A (USH2A) gene that encode multiple conserved functional domains and that are mutated in patients with Usher syndrome type II. American journal of human genetics. 2004. PMID: 15015129
- Bhattacharya G, Miller C, Kimberling WJ. Localization and expression of usherin: a novel basement membrane protein defective in people with Usher's syndrome type IIa. Hearing research. 2002. PMID: 11788194
- Adam MP, Bick S, Mirzaa GM. Usher Syndrome Type II. 1993. PMID: 20301515